Cunning Capital Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.81M Hold
2,342
1.13% 25
2026
Q1
$2.15M Hold
2,342
1.1% 35
2025
Q4
$2.52M Hold
2,342
1.16% 29
2025
Q3
$1.79M Hold
2,342
0.83% 45
2025
Q2
$1.83M Hold
2,342
0.95% 42
2025
Q1
$1.93M Sell
2,342
-13
-0.6% -$10.8K 1.23% 37
2024
Q4
$1.82M Hold
2,355
1.09% 42
2024
Q3
$2.09M Hold
2,355
1.09% 38
2024
Q2
$2.13M Hold
2,355
1.19% 27
2024
Q1
$1.83M Buy
+2,355
New +$1.68M 1.01% 45

Other funds holding LLY

Cunning Capital Partners's LLY Position: Q2 2026 in Review

Cunning Capital Partners held its Eli Lilly (LLY) position steady in Q2 2026 at 2,342 shares worth $2.81M. The position accounts for 1.13% of the portfolio, ranked #25.

Cunning Capital Partners first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. 4,634 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Cunning Capital Partners held 2,342 shares of Eli Lilly worth $2.81M as of Q2 2026.
  • Cunning Capital Partners left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 1.13% of Cunning Capital Partners's portfolio in Q2 2026, its #25 holding.
  • Cunning Capital Partners first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
  • 4,634 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Cunning Capital Partners's 13F filing for Q2 2026, filed 11 Aug 2026.